The United States of America;as represented by the Secretary;Department of Health and Human Services
发明人:
Raul E. Vizcardo,Naritaka Tamaoki,Meghan L. Good,Nicholas P. Restifo
申请号：
US16762447
公开号：
US20200263136A1
申请日:
2018.11.08
申请国别(地区):
US
年份:
2020
代理人:
摘要：
Disclosed are methods of preparing CD34+CD43+ hematopoietic progenitor cells (HPC) in vitro according to embodiments of the invention. Also disclosed are methods of differentiating CD34+CD43+ hematopoietic progenitor cells to hematopoietic lineage cells according to embodiments of the invention. Also disclosed are methods of treating or preventing a condition in a mammal, e.g., cancer, according to embodiments of the invention.
